These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38679727)

  • 1. Safety and efficacy of umbilical cord tissue-derived mesenchymal stem cells in the treatment of patients with aging frailty: a phase I/II randomized, double-blind, placebo-controlled study.
    Zhu Y; Huang C; Zheng L; Li Q; Ge J; Geng S; Zhai M; Chen X; Yuan H; Li Y; Jia W; Sun K; Li Y; Ye T; Zhao Z; Liu H; Liu Z; Jiang H
    Stem Cell Res Ther; 2024 Apr; 15(1):122. PubMed ID: 38679727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Tompkins BA; DiFede DL; Khan A; Landin AM; Schulman IH; Pujol MV; Heldman AW; Miki R; Goldschmidt-Clermont PJ; Goldstein BJ; Mushtaq M; Levis-Dusseau S; Byrnes JJ; Lowery M; Natsumeda M; Delgado C; Saltzman R; Vidro-Casiano M; Da Fonseca M; Golpanian S; Premer C; Medina A; Valasaki K; Florea V; Anderson E; El-Khorazaty J; Mendizabal A; Green G; Oliva AA; Hare JM
    J Gerontol A Biol Sci Med Sci; 2017 Oct; 72(11):1513-1522. PubMed ID: 28977399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.
    Gu J; Huang L; Zhang C; Wang Y; Zhang R; Tu Z; Wang H; Zhou X; Xiao Z; Liu Z; Hu X; Ke Z; Wang D; Liu L
    Stem Cell Res Ther; 2020 Feb; 11(1):43. PubMed ID: 32014055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study.
    Yang Y; Pang M; Du C; Liu ZY; Chen ZH; Wang NX; Zhang LM; Chen YY; Mo J; Dong JW; Xie PG; Wang QY; Liu B; Rong LM
    Cytotherapy; 2021 Jan; 23(1):57-64. PubMed ID: 33218835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial.
    Uccelli A; Laroni A; Ali R; Battaglia MA; Blinkenberg M; Brundin L; Clanet M; Fernandez O; Marriot J; Muraro P; Nabavi SM; Oliveri RS; Radue E; Ramo Tello C; Schiavetti I; Sellner J; Sorensen PS; Sormani MP; Wuerfel JT; Freedman MS;
    Lancet Neurol; 2021 Nov; 20(11):917-929. PubMed ID: 34687636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subarachnoid transplantation of human umbilical cord mesenchymal stem cell in rodent model with subacute incomplete spinal cord injury: Preclinical safety and efficacy study.
    Yang Y; Cao TT; Tian ZM; Gao H; Wen HQ; Pang M; He WJ; Wang NX; Chen YY; Wang Y; Li H; Lin JW; Kang Z; Li MM; Liu B; Rong LM
    Exp Cell Res; 2020 Oct; 395(2):112184. PubMed ID: 32707134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial.
    Lanzoni G; Linetsky E; Correa D; Messinger Cayetano S; Alvarez RA; Kouroupis D; Alvarez Gil A; Poggioli R; Ruiz P; Marttos AC; Hirani K; Bell CA; Kusack H; Rafkin L; Baidal D; Pastewski A; Gawri K; Leñero C; Mantero AMA; Metalonis SW; Wang X; Roque L; Masters B; Kenyon NS; Ginzburg E; Xu X; Tan J; Caplan AI; Glassberg MK; Alejandro R; Ricordi C
    Stem Cells Transl Med; 2021 May; 10(5):660-673. PubMed ID: 33400390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial.
    Shi L; Huang H; Lu X; Yan X; Jiang X; Xu R; Wang S; Zhang C; Yuan X; Xu Z; Huang L; Fu JL; Li Y; Zhang Y; Yao WQ; Liu T; Song J; Sun L; Yang F; Zhang X; Zhang B; Shi M; Meng F; Song Y; Yu Y; Wen J; Li Q; Mao Q; Maeurer M; Zumla A; Yao C; Xie WF; Wang FS
    Signal Transduct Target Ther; 2021 Feb; 6(1):58. PubMed ID: 33568628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Transplantation of Human Umbilical Cord Mesenchymal Stem Cells and Human Neural Stem Cells Improves the Outcome in Rats with Spinal Cord Injury.
    Sun L; Wang F; Chen H; Liu D; Qu T; Li X; Xu D; Liu F; Yin Z; Chen Y
    Cell Transplant; 2019 Jul; 28(7):893-906. PubMed ID: 31012325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Umbilical Cord Mesenchymal Stromal Cell Transplantation in Myocardial Ischemia (HUC-HEART Trial). A Study Protocol of a Phase 1/2, Controlled and Randomized Trial in Combination with Coronary Artery Bypass Grafting.
    Can A; Ulus AT; Cinar O; Topal Celikkan F; Simsek E; Akyol M; Canpolat U; Erturk M; Kara F; Ilhan O
    Stem Cell Rev Rep; 2015 Oct; 11(5):752-60. PubMed ID: 26123356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efficacy of allogeneic human mesenchymal stem cell infusion in patients with aging frailty.
    Golpanian S; DiFede DL; Pujol MV; Lowery MH; Levis-Dusseau S; Goldstein BJ; Schulman IH; Longsomboon B; Wolf A; Khan A; Heldman AW; Goldschmidt-Clermont PJ; Hare JM
    Oncotarget; 2016 Mar; 7(11):11899-912. PubMed ID: 26933813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical assessments of safety and tumorigenicity of very high doses of allogeneic human umbilical cord mesenchymal stem cells.
    Chin SP; Saffery NS; Then KY; Cheong SK
    In Vitro Cell Dev Biol Anim; 2024 Mar; 60(3):307-319. PubMed ID: 38421574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord mesenchymal stem cell transplantation for the treatment of acute-on-chronic liver failure: protocol for a multicentre random double-blind placebo-controlled trial.
    Wang Y; Li M; Yang T; Xie Y; Wang FS; Hu J; Shi M
    BMJ Open; 2024 Jun; 14(6):e084237. PubMed ID: 38925694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis.
    Deng D; Zhang P; Guo Y; Lim TO
    Ann Rheum Dis; 2017 Aug; 76(8):1436-1439. PubMed ID: 28478399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells (hUC-MSC PLEB001) for the treatment of grade II-IV steroid-refractory acute graft-versus-host disease: a study protocol for a multicenter, randomized, double-blind, placebo-controlled, phase II trial.
    Yang D; Hou X; Qian K; Li Y; Hu L; Li L; Han M; Yao C; Liu D
    Trials; 2023 May; 24(1):306. PubMed ID: 37138332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.
    Matas J; Orrego M; Amenabar D; Infante C; Tapia-Limonchi R; Cadiz MI; Alcayaga-Miranda F; González PL; Muse E; Khoury M; Figueroa FE; Espinoza F
    Stem Cells Transl Med; 2019 Mar; 8(3):215-224. PubMed ID: 30592390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
    Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
    J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Study of Mesenchymal Stem/Stromal Cell Therapy for the Treatment of Frailty: A Proposed Experimental Design for Therapeutic and Mechanistic Investigation.
    Hoang DM; Nguyen KT; Hoang VT; Dao LTM; Bui HT; Ho TTK; Nguyen TTP; Ngo ATL; Nguyen HK; Thanh LN
    J Gerontol A Biol Sci Med Sci; 2022 Jul; 77(7):1287-1291. PubMed ID: 34718548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.